Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Asima Mukhopadhyay.

Newcastle AuthorsTitleYearFull text
Dr Santu Saha
Dr Stuart Rundle
Dr Ioannis Kotsopoulos
Dr Jake Begbie
Rachel Howarth
et al.
Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy2022
Hannah Smith
Dr Elaine Willmore
Dr Asima Mukhopadhyay
Dr Yvette Drew
Professor Nicola Curtin
et al.
Differences in Durability of PARP Inhibition by Clinically Approved PARP Inhibitors: Implications for Combinations and Scheduling2022
Dr Asima Mukhopadhyay
Economic evaluation of population-based BRCA1/BRCA2 mutation testing across multiple countries and health systems2020
Dr Asima Mukhopadhyay
Dr Yvette Drew
Liz Matheson
Dr Mo Salehan
Lucy Gentles
et al.
Evaluating the potential of kinase inhibitors to suppress DNA repair and sensitise ovarian cancer cells to PARP inhibitors2019
Lucy Gentles
Bojidar Goranov
Elizabeth Matheson
Dr Ashleigh Herriott
Dr Angelika Kaufmann
et al.
Exploring the frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types2019
Dr Asima Mukhopadhyay
Autophagy-independent induction of LC3B through oxidative stress reveals its non-canonical role in anoikis of ovarian cancer cells2018
Dr Ioannis Kotsopoulos
Dr Asima Mukhopadhyay
Professor John Lunec
Professor Nicola Curtin
Ali Kucukmetin
et al.
IN VITRO SINGLE AGENT RUCAPARIB CYTOTOXICITY AND CISPLATIN CHEMO-POTENTIATION IN CERVICAL CANCER CELL LINES2016
Dr Ganiy Abdulrahman
Elizabeth Matheson
Dr Yvette Drew
Professor Nicola Curtin
Dr Asima Mukhopadhyay
et al.
Investigating PARP inhibitor sensitisation by hyperthermia and HSP90 inhibition2016
Dr Rachel O'Donnell
Dr Stuart Rundle
Dr Ioannis Kotsopoulos
Chun Ang
Ali Kucukmetin
et al.
Metastatic involvement of the lesser sac in advanced epithelial ovarian cancer2016
Dr Asima Mukhopadhyay
Ovarian cysts and cancer in pregnancy2016
Dr Ioannis Kotsopoulos
Ali Kucukmetin
Dr Asima Mukhopadhyay
Professor John Lunec
Professor Nicola Curtin
et al.
Poly(ADP-Ribose) Polymerase in Cervical Cancer Pathogenesis Mechanism and Potential Role for PARP Inhibitors2016
Elizabeth Matheson
Dr Mo Salehan
Dr Asima Mukhopadhyay
Professor Nicola Curtin
Dr Yvette Drew
et al.
Preclinical studies of the PARP inhibitor olaparib in combination with imatinib in BRCA stratified ovarian cancer2016
Dr Rachel O'Donnell
Dr Stuart Rundle
Dr Ioannis Kotsopoulos
Chun Ang
Ali Kucukmetin
et al.
Risk factors for lesser sac metastasis in advanced ovarian cancer.2016
Dr Asima Mukhopadhyay
Michelle Dixon
Dr Evan Mulligan
James Murray
Professor Nicola Curtin
et al.
Evaluation of different methods to assess homologous recombination status and sensitivity to parp inhibitors in ovarian cancer2014
Professor Richard Edmondson
Dr Asima Mukhopadhyay
Professor Nicola Curtin
Molecular characterization of matched ovarian ascites and tumors suggests multiple mechanisms for a homologous recombination defective phenotype2014
Dr Rachel O'Donnell
Dr Aiste McCormick
Dr Asima Mukhopadhyay
Michelle Dixon
Dr Angelika Kaufmann
et al.
The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis2014
Dr Rachel O'Donnell
Laura Woodhouse
Dr Aiste McCormick
Dr Asima Mukhopadhyay
Michelle Dixon
et al.
Functional Intra-Tumour Heterogeneity in Ovarian Cancer: What is a Representative Tumour Sample?2013